Homocysteine-mediated thrombosis and angiostasis in vascular pathobiology

Journal of Clinical Investigation

Volumn 119, Issue 11, 2009, Pages 3203-3205

  Loscalzo, Joseph ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; HOMOCYSTEINE; LIPOCORTIN 2; PLASMINOGEN; THROMBOSPONDIN 1; TISSUE PLASMINOGEN ACTIVATOR;

ANGIOGENESIS; FIBRIN CLOT; FIBRINOLYSIS; HUMAN; HYPERHOMOCYSTEINEMIA; ISCHEMIA; NONHUMAN; NOTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROCESSING; THROMBOGENESIS; THROMBOSIS;

ANIMALS; ANNEXIN A2; HOMOCYSTEINE; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; THROMBOSIS;

EID: 70449394645     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI40924     Document Type: Note

References (31)

1. Maron, B., and Loscalzo, J. 2009. The treatment of hyperhomocysteinemia. Annu. Rev. Med. 60:39-54.
2. Eberhardt, R.T., et al. 2000. Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J. Clin. Invest. 106:483-491. (Pubitemid 30666381)
3. Upchurch, G.R., Jr., et al. 1997. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J. Biol. Chem. 272:17012-17017.
4. Heydrick, S.J., et al. 2004. L-Homocysteine and L-homocystine stereospecifically induce endothelial nitric oxide synthase-dependent lipid peroxidation in endothelial cells. Free Radic. Biol. Med. 36:632-640.
5. Dayal, S., and Lentz, S.R. 2008. Murine models of hyperhomocysteinemia and their vascular phenotypes. Arterioscler. Thromb. Vasc. Biol. 28:1596-1605.
6. Dayal, S., and Lentz, S.R. 2007. Role of redox reactions in the vascular phenotype of hyperhomocysteinemic animals. Antioxid. Redox Signal. 9:1899-1909. (Pubitemid 47628606)
7. Handy, D.E., Zhang, Y., and Loscalzo, J. 2005. Homocysteine downregulates glutathione peroxidase (GPx1) by decreasing translation. J. Biol. Chem. 280:15518-15525. (Pubitemid 40616667)
8. Handy, D.E., et al. 2009. Glutathione peroxidase-1 regulates mitochondrial function to modulate redox-dependent cellular responses. J. Biol. Chem. 284:11913-11921.
9. Weiss, N., Zhang, Y.Y., Heydrick, S., Bierl, C., and Loscalzo, J. 2001. Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction. Proc. Natl. Acad. Sci. U. S. A. 98:12503-12508. (Pubitemid 33019975)
10. Ungvari, Z., et al. 2003. Increased superoxide production in coronary arteries of hyperhomocysteinemia: role of tumor necrosis factor-alpha, NAD(P)H oxidase, and inducible nitric oxide synthase. Arterioscler. Thromb. Vasc. Biol. 23:418-424. (Pubitemid 36337217)
11. Topal, G., et al. 2004. Homocysteine induces oxidative stress by uncoupling of NO synthase activity through reduction of tetrahydrobiopterin. Free Radic. Biol. Med. 36:1532-1541. (Pubitemid 38746561)
12. Vitvitsky, V., et al. 2004. Perturbations in homocysteine-linked redox homeostasis in a murine model for hyperhomocysteinemia. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287:R39-R46. (Pubitemid 38856309)
13. Dayal, S., et al. 2005. Enhanced susceptibility to arterial thrombosis in a murine model of hyperhomocysteinemia. Blood. 108:2237-2243.
14. Undas, A., Brozek, J., and Szczeklik, A. 2005. Homocysteine and thrombosis: from basic science to clinical evidence. Thromb. Haemost. 94:907-915. (Pubitemid 41645928)
15. Sauls, D.L., et al. 2006. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia. Biochemistry. 45:2480-2487.
16. Colucci, M., et al. 2008. Mild hyperhomocysteinemia is associated with increased TAFI levels and reduced plasma fibrinolytic potential. J. Thromb. Haemost. 6:1571-1577.
17. Jacovina, A.T., et al. 2009. Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis. J. Clin. Invest. 119:3384-3394.
18. Hajjar, K.A., et al. 1998. Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine. J. Biol. Chem. 273:9987-9993.
19. Ling, Q., et al. 2004. Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo. J. Clin. Invest. 113:38-48. (Pubitemid 38541630)
20. Galasso, G., et al. 2006. Impaired angiogenesis in glutathione peroxidase-1-deficient mice is associated with endothelial progenitor cell dysfunction. Circ. Res. 98:254-261. (Pubitemid 43755357)
21. Kundu, S., et al. 2009. Nitrotyrosinylation, remodeling and endothelial-myocyte uncoupling in iNOS, cystathionine beta synthase (CBS) knockouts and iNOS/CBS double knockout mice. J. Cell. Biochem. 106:119-126.
22. Koo, B.-H., Park, M.Y., Jeon, O.-H., and Kim, D.-S. 2009. Regulatory mechanism of MMP-2 enzymatic activity by factor Xa and thrombin. J. Biol. Chem. 284:23375-23385.
23. O'Reilly, M.S., et al. 1997. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 88:277-285. (Pubitemid 28015876)
24. Sodha, N.R., et al. 2009. Endostatin and angiostatin are increased in diabetic patients with coronary artery disease and associated with impaired coronary collateral formation. Am. J. Physiol. Heart Circ. Physiol. 296:H428-H434.
25. Guimarães, A.H., et al. 2007. TAFI and pancreatic carboxypeptidase B modulate in vitro capillary tube formation by human microvascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 27:2157-2162.
26. Romer, J., et al. 1996. Impaired wound healing in mice with a disrupted plasminogen gene. Nat. Med. 2:287-292. (Pubitemid 26080649)
27. Bootle-Wilbraham, C.A., Tazzyman, S., Thompson, W.D., Stirk, C.M., and Lewis, C.E. 2001. Fibrin fragment E stimulates proliferation, migration and differentiation of human microvascular endothelial cells in vitro. Angiogenesis. 4:269-275. (Pubitemid 34832372)
28. Dardik, R., Loscalzo, J., Eskaraev, R., and Inbal, A. 2005. Molecular mechanisms underlying the proangiogenic effect of factor XIII. Arterioscler. Thromb. Vasc. Biol. 25:526-532. (Pubitemid 40315673)
29. Ingrosso, D., and Perna, A.F. 2009. Epigenetics in hyperhomocysteinemic states: a special focus on uremia. Biochim. Biophys. Acta. 1790:892-899.
30. Gao, S., Skeldal, S., Krogdahl, A., Sorensen, J.A., and Andreasen, P.A. 2005. CpG methylation of the PAI-1 gene 5'-flanking region is inversely correlated with PAI-1 mRNA levels in human cell lines. Thromb. Haemost. 94:651-660. (Pubitemid 41300865)
31. Hu, C.J., et al. 2006. Promoter region methylation and reduced expression of thrombospondin-1 after oxygen deprivation in murine cerebral endothelial cells. J. Cereb. Blood Flow Metab. 26:1519-1526.